Preclinical Data From Cytotil15 Program Equipment Supplied In Ireland
3 equipment items found
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
Development of Bentrio™ (AM-301) has been completed. The product has been introduced to the market, starting in selected countries of the European ...
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
AM-125 for the treatment of vertigo is expected to complete its Phase 2 TRAVERS trial in Q2 2022 and to move into Phase 3 in Q4 2022. Keyzilen® (AM-101) for the treatment of acute inner ear tinnitus and Sonsuvi® (AM-111) for the treatment of acute inner ear hearing loss have both been evaluated in Phase 3 trials, but will require further clinical testing. ...
Manufactured by:Auris Medical AG based inBasel, SWITZERLAND
The OligoPhore™ / SemaPhore™ technology has been extensively and successfully tested with various siRNA and mRNA sequences in numerous disease models in mice. For the development of our first proprietary drug product, AM-401 (OligoPhore™ siRNA targeting KRAS), we have initiated a program of IND-enabling ...